Global Launch Of The Lancet Series On Ending Preventabl...
Hosted by the MARCH Centre DATE: Tuesday, 19 January 2016 TIME: 5:00 p.m. – 6:45 p.m. [UK]
Hosted by the MARCH Centre DATE: Tuesday, 19 January 2016 TIME: 5:00 p.m. – 6:45 p.m. [UK]
First Candle will be hosting the US launch of the latest lancet research on ENDING PREVENTABLE STILLBIRTHS in NEW YORK CITY on 19 JANUARY, 2016.
NEW “ENDING PREVENTABLE STILLBIRTHS” lancet SERIES – MAINTAINING MOMENTUM IN the GLOBAL CALL TO ACTION Following the successful launch of the lancet’s Stillbirth Ser...
Facebook CEO Mark Zuckerberg appears to have made clear where he stands on the issue of childhood vaccines. the billionaire posted a photo on his Facebook page of him holding ...
http://www.voanews.com/content/mht-zuckerberg-photo-viral-vaccine/3140416.html
Melanie Lawson, Founder of Bare Biology Omega 3, talks to Baby London about your baby’s brain development. During pregnancy, women are advised to make sure they have enough...
http://babylondon.co.uk/the-experts-boost-your-babys-brain-growth/
Reducing the amount of sugar in sugar-sweetened beverages by 40% over five years could prevent 300,000 cases of type 2 diabetes in the UK over the next two decades, according ...
Studies from Britain and Mexico suggest reducing sugar in sweetened drinks or taxing it more to cut consumption can help people limit their calorie intake and lower their r...
Mucho se ha hablado acerca del estado de ánimo que transitamos y su relación con la salud, pero una investigación [http://www.thelancet.com/journals/lancet/article/PIIS0140...
http://feeds.weblogssl.com/~r/Vitonica/~3/dZIPvHRVsyg/la-felicidad-no-te-vuelve-mas-saludable
LabStyle Innovations, an Israeli firm, won FDA clearance for its Dario glucose monitoring system. the Dario includes a smartphone-connected glucometer and an Apple iOS app tha...
BY: SWIKAR OLI A 14-year study of over 200,000 women recently published in the lancet may have brought us closer than we have ever been to screening for ovarian cancer. Effect...
DCIS (ductal carcinoma in situ) is the most common form of non-invasive breast cancer and is considered stage 0 cancer. While DCIS isn’t life threatening, it increases the r...
http://www.breastcancer.org/research-news/arimidex-tamoxifen-reduce-recur-risk-equally
Transgene SA has announced that the results from the Phase 2b part of the Phase 2b/3 TIME trial with TG4010 immunotherapy in non-small cell lung cancer (NSCLC) have been publi...